News

ABQ Health Partners will monitor and analyze the performance of its Electronic Health Record (EHR) solution with the help of Aternity. Aternity will provide FPI Platform, transforming desktop

Through the initiative, development of a screening program to test tumours for major genetic changes will occur. In addition, it will aid in genetic testing of both patients

MANF is a protein that corrects protein misfolding, which is the primary cause of apoptosis (cell death). Under the collaboration, Amarantus will utilize its expertise in Central Nervous

BL-1020 is a oral, GABA-enhanced antipsychotic drug candidate used for the treatment of schizophrenia. The double-blinded, randomized and positive-controlled study will enroll up to 450 patients who are

The entitled patent owned by Hoffman-La Roche’s (Roche) was licensed to Amgen upon a one-time payment and received an exclusive, fully paid-up license to the application which issued

As per the deal, Harborview Medical Center will be provided with Daxor’s Blood Volume Analyzer-100 (BVA-100), which is used for semi-automated measurement of total blood volume, red blood

As per the agreement, the Medical Center will receive Daxor’s Blood Volume Analyzer-100 (BVA-100) which is used for semi-automated measurement of total blood volume, red blood cell volume

The pivotal double-blinded trial was designed to assess the safety and efficacy of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prosta te cancer (CRPC).

The placebo-controlled, randomized 24-month study was designed to demonstrate the safety and efficacy of DiaPep277 in newly diagnosed patients with T1D. The study met primary endpoint defined as